MX336586B - Nuevos peptidos con efectos analgesicos y que inhiben los canales asic. - Google Patents
Nuevos peptidos con efectos analgesicos y que inhiben los canales asic.Info
- Publication number
- MX336586B MX336586B MX2013001020A MX2013001020A MX336586B MX 336586 B MX336586 B MX 336586B MX 2013001020 A MX2013001020 A MX 2013001020A MX 2013001020 A MX2013001020 A MX 2013001020A MX 336586 B MX336586 B MX 336586B
- Authority
- MX
- Mexico
- Prior art keywords
- peptides
- asic channels
- channels
- analgesic effects
- inhibit asic
- Prior art date
Links
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 4
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 4
- 230000000202 analgesic effect Effects 0.000 title abstract 3
- 102000001671 Acid Sensing Ion Channels Human genes 0.000 abstract 3
- 108010068806 Acid Sensing Ion Channels Proteins 0.000 abstract 3
- 241000272023 Dendroaspis polylepis Species 0.000 abstract 1
- 230000036592 analgesia Effects 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 102000040430 polynucleotide Human genes 0.000 abstract 1
- 108091033319 polynucleotide Proteins 0.000 abstract 1
- 239000002157 polynucleotide Substances 0.000 abstract 1
- 239000013598 vector Substances 0.000 abstract 1
- 239000002435 venom Substances 0.000 abstract 1
- 210000001048 venom Anatomy 0.000 abstract 1
- 231100000611 venom Toxicity 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Rheumatology (AREA)
- Psychiatry (AREA)
- Physical Education & Sports Medicine (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR1003136A FR2963010B1 (fr) | 2010-07-26 | 2010-07-26 | Nouveaux peptides avec des effets analgesiques et inhibant les canaux asic |
| PCT/FR2011/051800 WO2012022894A1 (fr) | 2010-07-26 | 2011-07-26 | Nouveaux peptides avec des effets analgesiques et inhibant les canaux asic |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2013001020A MX2013001020A (es) | 2014-04-14 |
| MX336586B true MX336586B (es) | 2016-01-21 |
Family
ID=43589927
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2013001020A MX336586B (es) | 2010-07-26 | 2011-07-26 | Nuevos peptidos con efectos analgesicos y que inhiben los canales asic. |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US8987207B2 (OSRAM) |
| EP (1) | EP2598523B1 (OSRAM) |
| JP (1) | JP6000245B2 (OSRAM) |
| CN (1) | CN103097404B (OSRAM) |
| AU (1) | AU2011290589A1 (OSRAM) |
| BR (1) | BR112013001863A2 (OSRAM) |
| CA (1) | CA2806471C (OSRAM) |
| FR (1) | FR2963010B1 (OSRAM) |
| MX (1) | MX336586B (OSRAM) |
| RU (1) | RU2583299C2 (OSRAM) |
| SG (1) | SG187877A1 (OSRAM) |
| WO (1) | WO2012022894A1 (OSRAM) |
| ZA (1) | ZA201300662B (OSRAM) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105233286B (zh) * | 2015-09-10 | 2018-10-30 | 上海交通大学医学院 | 含酸敏感离子通道调控剂的制剂及其在治疗瘙痒中的用途 |
| CN105412932B (zh) * | 2015-10-26 | 2019-08-16 | 上海交通大学医学院 | 含ASIC1a与RIP1结合抑制剂的制剂及其抑制神经元死亡的用途 |
| CN112618722A (zh) * | 2016-11-22 | 2021-04-09 | 上海交通大学医学院 | 酸敏感离子通道调控剂的用途 |
| CN107384952A (zh) * | 2017-08-23 | 2017-11-24 | 湖南甲骨文生物医药有限公司 | 用于筛选ASICs作用蛋白的酵母双杂交诱饵载体的构建方法 |
| CN114729034B (zh) * | 2019-06-04 | 2024-01-12 | 上海科技大学 | 亲和力成熟的抗ASIC1a抗体 |
| RU2768484C1 (ru) * | 2021-05-24 | 2022-03-24 | Закрытое акционерное общество "СКАЙ ЛТД" | Фармацевтическая композиция иммуностимулирующих веществ мурамилпептидной природы |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5776896A (en) | 1996-01-03 | 1998-07-07 | Zeneca Limited | Analgesic peptides from venom of grammostola spatulata and use thereof |
| JP4959226B2 (ja) * | 2006-05-19 | 2012-06-20 | 独立行政法人産業技術総合研究所 | スリーフィンガー様蛋白質ライブラリ |
| JP2008193923A (ja) * | 2007-02-09 | 2008-08-28 | Janusys Kk | 蛋白質ライブラリ |
-
2010
- 2010-07-26 FR FR1003136A patent/FR2963010B1/fr not_active Expired - Fee Related
-
2011
- 2011-07-26 US US13/812,457 patent/US8987207B2/en active Active
- 2011-07-26 CA CA2806471A patent/CA2806471C/fr active Active
- 2011-07-26 SG SG2013011705A patent/SG187877A1/en unknown
- 2011-07-26 EP EP11752299.5A patent/EP2598523B1/fr active Active
- 2011-07-26 RU RU2013108262/10A patent/RU2583299C2/ru active
- 2011-07-26 WO PCT/FR2011/051800 patent/WO2012022894A1/fr not_active Ceased
- 2011-07-26 AU AU2011290589A patent/AU2011290589A1/en not_active Abandoned
- 2011-07-26 JP JP2013521194A patent/JP6000245B2/ja active Active
- 2011-07-26 BR BR112013001863A patent/BR112013001863A2/pt not_active Application Discontinuation
- 2011-07-26 CN CN201180043328.6A patent/CN103097404B/zh active Active
- 2011-07-26 MX MX2013001020A patent/MX336586B/es unknown
-
2013
- 2013-01-24 ZA ZA2013/00662A patent/ZA201300662B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| SG187877A1 (en) | 2013-03-28 |
| EP2598523A1 (fr) | 2013-06-05 |
| CA2806471A1 (fr) | 2012-02-23 |
| ZA201300662B (en) | 2013-09-25 |
| FR2963010B1 (fr) | 2014-08-15 |
| AU2011290589A1 (en) | 2013-03-07 |
| US20130196923A1 (en) | 2013-08-01 |
| RU2013108262A (ru) | 2014-09-10 |
| CN103097404B (zh) | 2015-09-16 |
| JP2013535965A (ja) | 2013-09-19 |
| MX2013001020A (es) | 2014-04-14 |
| CA2806471C (fr) | 2020-07-07 |
| RU2583299C2 (ru) | 2016-05-10 |
| US8987207B2 (en) | 2015-03-24 |
| WO2012022894A4 (fr) | 2012-04-12 |
| FR2963010A1 (fr) | 2012-01-27 |
| WO2012022894A1 (fr) | 2012-02-23 |
| EP2598523B1 (fr) | 2015-09-09 |
| JP6000245B2 (ja) | 2016-09-28 |
| CN103097404A (zh) | 2013-05-08 |
| BR112013001863A2 (pt) | 2016-05-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12020550156A1 (en) | 4-1bb binding molecules | |
| MX2013001020A (es) | Nuevos peptidos con efectos analgesicos y que inhiben los canales asic. | |
| BR112012029975A2 (pt) | peptídeo como medicamento, em particular para o tratamento do câncer. | |
| AR068552A1 (es) | Polipeptidos y polinucleotidos del fago omegamru y sus usos para detectar, apuntar e inhibir celulas microbianas metanogenicas | |
| MX2014009975A (es) | Composiciones del vector aav y metodos para su transferencia genetica a celulas, organos y tejidos. | |
| MY161268A (en) | PEPTIDE OR PEPTIDE COMPLEX BINDING TO α2 INTEGRIN AND METHODS AND USES INVOLVING THE SAME | |
| MX337984B (es) | Variantes de alfa amilasa y polinucleotidos que codifican la misma. | |
| IN2014CN04586A (OSRAM) | ||
| EP4253534A3 (en) | Alpha-amylase variants and polynucleotides encoding same | |
| MX2013004892A (es) | Polipeptidos que tienen actividad de fosfolipasa c y polinucleotidos que codifican los mismos. | |
| MX356625B (es) | Oligonucleotidos para elaborar un cambio en la secuencia de una molécula de ácido ribonucleico objetivo presente en una célula viva. | |
| MX2013007716A (es) | Sistemas de expresion. | |
| EA201590162A1 (ru) | МУТАНТНЫЕ ФРАГМЕНТЫ OspA И СВЯЗАННЫЕ С НИМИ СПОСОБЫ И ПРИМЕНЕНИЕ | |
| MX2014004598A (es) | Variantes de alfa-amilasa y polinucleotidos que codifican las mismas. | |
| WO2013119302A3 (en) | Gh61 polypeptide variants and polynucleotides encoding same | |
| IN2014DN06164A (OSRAM) | ||
| EP3279320A3 (en) | Gh61 polypeptide variants and polynucleotides encoding same | |
| EP2488641A4 (en) | SUPERGESPULED MINICIRCLE DNA FOR GENE THERAPY APPLICATIONS | |
| RU2015112625A (ru) | Пептид, применение пептида для лечения сердечно-сосудистых заболеваний, нуклеотидная последовательность, вектор экспрессии, хозяйская клетка, фармацевтическая композиция | |
| MY173686A (en) | Fc gamma receptor iib variants | |
| WO2009111336A3 (en) | Methods of purifying plasmid dna | |
| WO2013181404A3 (en) | COMPOSITIONS AND METHODS FOR PEPTIDE EXPRESSION AND PURIFICATION USING A TYPE lll SECRETION SYSTEM | |
| PH12014500720A1 (en) | Topk peptides and vaccines including the same | |
| MX350713B (es) | Variantes de subtilisina y polinucleotidos que las codifican. | |
| WO2009106532A3 (en) | Use of prokaryotic tir-domain containing proteins as therapeutic and diagnostic agents |